Examining the FDA's evolving role in regulating Super Bowl drug ads to ensure patient-focused healthcare marketing.

On September 9, 2025, the U.S. Food and Drug Administration (FDA) and Department of Health and Human Services (HHS) dropped a regulatory bombshell: the FDA issued approximately 100 cease-and-desist ...

Additionally, the agency is eliminating the 'adequate provision' loophole that allowed pharmaceutical companies to list complete risks separately. (HealthDay News) — The U.S. Food and Drug ...

The Food and Drug Administration has announced that it is cracking down on direct-to-consumer (DTC) prescription drug advertising. It sent out around 100 letters to drug companies warning that many ...

The Trump administration’s crackdown on pharmaceutical ads is a welcome step toward lessening Big Pharma’s influence over conversations between patients and their doctors. Americans are among the few ...

The U.S. Department of Health and Human Services and the Food and Drug Administration announced major reform on Tuesday that requires pharmaceutical companies to include full safety warnings in direct ...

President Donald Trump on Tuesday signed a memorandum that aims to crack down on direct-to-consumer prescription drug ads. The U.S. Department of Health and Human Services and the Food and Drug ...

Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different look: New rules require drugmakers to be clearer and more direct when ...

Rulemaking to remove its longstanding “adequate provision” framework, described as a “loophole” undermining “informed patient consent” that has allegedly enabled companies to “hide safety information.

The FDA has also initiated rulemaking to eliminate the 1997 "adequate provision" loophole, which allowed companies to include a "major-risk statement" and then direct viewers to a website, toll-free ...

The Trump administration’s crackdown on pharmaceutical ads is a welcome step toward lessening Big Pharma’s influence over conversations between patients and their doctors. Americans are among the few ...

FRIDAY, Sept. 12, 2025 (HealthDay News) -- The U.S. Food and Drug Administration is taking new steps to regulate direct-to-consumer drug advertisements and eliminate misleading advertisements out of ...